PMID: 2493533Jan 1, 1989Paper

The incidence of legionella pneumonia: a 1-year prospective study in a large community hospital

Lung
B RufH D Pohle

Abstract

In a 1-year prospective study, 28 of 476 pneumonia patients (5.9%) were diagnosed as having legionella pneumonia. Legionella pneumonia was diagnosed in 12 (5%) of 240 community-acquired pneumonias and in 16 (6.8%) of 236 nosocomial pneumonias. Four methods of establishing diagnosis were used: serum antibody detection, direct proof of legionellae by immunofluorescence, culture, and legionella antigen detection in urine. The latter method proved to be clearly advantageous to all other methods in establishing the diagnosis. Twelve of the 28 patients (42.8%) died; all of them had severe underlying diseases. The fatality rate in patients treated with erythromycin was 18.8% (3/16 cases) and 75% (9/12 cases) in patients treated with antibiotics other than erythromycin. In 57.1% (16/28 patients) legionella pneumonia was acquired nosocomially. The results of our study underscore the need to use a broad spectrum of legionella diagnostic methods routinely and to administer antibiotics effective against legionellae in cases of pneumonia of unknown cause.

References

Dec 1, 1977·The New England Journal of Medicine·F W ChandlerJ A Blackmon
Dec 1, 1977·The New England Journal of Medicine·D W FraserP S Brachman
Sep 1, 1978·Journal of Clinical Microbiology·W B CherryR E Weaver
Oct 1, 1979·Journal of Clinical Microbiology·J C FeeleyW B Baine
Sep 1, 1987·Infectious Disease Clinics of North America·W T Ching, R D Meyer
Apr 1, 1986·Southern Medical Journal·J E Rudin, E J Wing
Aug 1, 1986·Archives of Internal Medicine·R R MuderA H Woo
Jan 1, 1986·Scandinavian Journal of Infectious Diseases·A Friis-MøllerO Aalund
Nov 1, 1986·The Journal of Infection·M A WoodheadS F Pugh
Mar 8, 1985·JAMA : the Journal of the American Medical Association·K N ShandsD W Fraser
May 1, 1985·The Journal of Infection·M A WoodheadA D Macrae
Aug 1, 1985·The Journal of Infectious Diseases·P L MeenhorstR van Furth
Aug 1, 1973·American Journal of Clinical Pathology·R C Brown, H C Hopps
Jul 31, 1982·Lancet·J T MacfarlaneA D Macrae
Mar 1, 1983·Reviews of Infectious Diseases·R D Meyer
Oct 1, 1984·Journal of Clinical Microbiology·R B KohlerL J Wheat
May 1, 1984·The Journal of Infectious Diseases·A L ReingoldJ N Kuritsky
Jun 17, 1983·JAMA : the Journal of the American Medical Association·R R MuderR M Lumish
Sep 1, 1982·The American Journal of Medicine·V L YuM Magnussen
Nov 1, 1981·Applied and Environmental Microbiology·R M Wadowsky, R B Yee
Jun 1, 1980·The Journal of Infectious Diseases·A W PasculleJ N Dowling

❮ Previous
Next ❯

Citations

Oct 18, 2000·Diagnostic Microbiology and Infectious Disease·C McNallyJ F Plouffe
Jul 30, 2002·The Lancet Infectious Diseases·Miguel Sabria, Victor L Yu
Jan 16, 1992·The New England Journal of Medicine·J E StoutL S Tompkins
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph F PlouffeDouglas B Schwartz
Jun 4, 2008·Medicine·Kalen L JacobsonDimitrios P Kontoyiannis
Jul 1, 1993·The American Journal of Medicine·S P BlattG P Melcher
Nov 2, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M WoodheadUNKNOWN Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases
May 10, 2005·Journal of the American Geriatrics Society·Meena H SeenivasanRobert R Muder
Nov 30, 2005·Internal Medicine Journal·P A Wilson, J Ferguson
Jun 1, 1997·Australian and New Zealand Journal of Public Health·J N HannaG Bapty
Jun 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M LouieL E Nicolle
Feb 27, 2013·Annals of Medical and Health Sciences Research·Io Onwuekwe, B Ezeala-Adikaibe
Oct 14, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M MusherJohn G Bartlett
Oct 30, 2001·The Medical Clinics of North America·S K Gupta, G A Sarosi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.